| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2009-11-02 | 2009-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 29,936 | Sold Some | -850 | -2.76 % | $1,569,544 | $1,683,900 | $114,356 | 7.28 % | $-3,247 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2009-07-31 | 2009-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 30,786 | Sold Some | -1,115 | -3.49 % | $1,918,276 | $1,731,713 | $-186,563 | -9.72 % | $6,757 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2009-05-04 | 2009-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 31,901 | Added More | 395 | 1.25 % | $1,547,518 | $1,794,431 | $246,914 | 15.95 % | $3,057 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2009-02-12 | 2008-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 31,506 | Added More | 3,378 | 12.00 % | $1,840,265 | $1,772,213 | $-68,053 | -3.69 % | $-7,296 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2008-11-07 | 2008-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 28,128 | Sold Some | -605 | -2.10 % | $1,655,895 | $1,582,200 | $-73,695 | -4.45 % | $1,585 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2008-08-01 | 2008-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 28,733 | Added More | 1,842 | 6.84 % | $1,803,858 | $1,616,231 | $-187,626 | -10.40 % | $-12,028 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2008-05-14 | 2008-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 26,891 | Added More | 3,376 | 14.35 % | $1,134,800 | $1,512,619 | $377,819 | 33.29 % | $47,433 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2008-02-14 | 2007-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 23,515 | Sold Some | -2,732 | -10.40 % | $1,099,797 | $1,322,719 | $222,922 | 20.26 % | $-25,899 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2007-11-14 | 2007-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 26,247 | Added More | 74 | 0.28 % | $1,407,627 | $1,476,394 | $68,767 | 4.88 % | $194 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2007-08-14 | 2007-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 26,173 | Sold Some | -1,930 | -6.86 % | $1,343,198 | $1,472,231 | $129,033 | 9.60 % | $-9,515 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2007-05-15 | 2007-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 28,103 | Added More | 1,975 | 7.55 % | $1,517,843 | $1,580,794 | $62,951 | 4.14 % | $4,424 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2007-02-13 | 2006-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 26,128 | Sold Some | -584 | -2.18 % | $1,797,606 | $1,469,700 | $-327,906 | -18.24 % | $7,329 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2006-11-13 | 2006-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 26,712 | Added More | 1,540 | 6.11 % | $1,941,962 | $1,502,550 | $-439,412 | -22.62 % | $-25,333 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2006-08-09 | 2006-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 25,172 | Added More | 520 | 2.10 % | $1,693,572 | $1,415,925 | $-277,647 | -16.39 % | $-5,736 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2006-05-15 | 2006-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 24,652 | Added More | 863 | 3.62 % | $1,721,449 | $1,386,675 | $-334,774 | -19.44 % | $-11,720 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2006-02-13 | 2005-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 23,789 | Sold Some | -110 | -0.46 % | $1,692,349 | $1,338,131 | $-354,218 | -20.93 % | $1,638 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2005-11-10 | 2005-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 23,899 | Sold Some | -122 | -0.50 % | $1,955,177 | $1,344,319 | $-610,858 | -31.24 % | $3,118 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2005-08-12 | 2005-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 24,021 | Sold Some | -30 | -0.12 % | $1,931,769 | $1,351,181 | $-580,588 | -30.05 % | $725 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2005-05-11 | 2005-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 24,051 | Added More | 587 | 2.50 % | $1,477,212 | $1,352,869 | $-124,344 | -8.41 % | $-3,035 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2005-02-10 | 2004-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 23,464 | Added More | 1,010 | 4.49 % | $1,473,070 | $1,319,850 | $-153,220 | -10.40 % | $-6,595 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2004-11-12 | 2004-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 22,454 | Added More | 295 | 1.33 % | $1,346,566 | $1,263,038 | $-83,529 | -6.20 % | $-1,097 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2004-08-11 | 2004-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 22,159 | Sold Some | -219 | -0.97 % | $1,223,177 | $1,246,444 | $23,267 | 1.90 % | $-230 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2004-05-12 | 2004-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 22,378 | Added More | 88 | 0.39 % | $1,283,155 | $1,258,763 | $-24,392 | -1.90 % | $-96 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2004-02-11 | 2003-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 22,290 | Added More | 694 | 3.21 % | $1,467,574 | $1,253,813 | $-213,761 | -14.56 % | $-6,655 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2003-11-12 | 2003-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 21,596 | Added More | 340 | 1.59 % | $1,301,807 | $1,214,775 | $-87,032 | -6.68 % | $-1,370 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2003-08-29 | 2003-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 21,256 | Added More | 1,675 | 8.55 % | $1,401,621 | $1,195,650 | $-205,971 | -14.69 % | $-16,231 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2003-05-13 | 2003-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 19,581 | Added More | 1,697 | 9.48 % | $1,204,232 | $1,101,431 | $-102,800 | -8.53 % | $-8,909 | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
| 2003-02-14 | 2002-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 17,884 | No Compare | - | - % | $940,698 | $1,005,975 | $65,277 | 6.93 % | | | | | | | History of Dowling And Yahnke Inc Ownership Of Amgen Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |